PTC Therapeutics director Michael Schmertzler sells $158k in shares
Covered in this story
Analyst targets on PTC Inc.
- BMO Capital Markets: $192 → $205 by Oct 2027 · Market Perform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $PTC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on PTC Inc. →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.